莱沃多巴度的波动和帕金森病.

HD-MUNet: integrating artificial intelligence and high-density electromyography for motor unit number estimation.

IEEE transactions on bio-medical engineering·2026

Validity and reliability of the Italian version of the short Parkinson's evaluation scale (SPES/SCOPA).

Heliyon·2024

Correlation between Quality of Life and severity of Parkinson's Disease by assessing an optimal cut-off point on the Parkinson's Disease questionnaire (PDQ-39) as related to the Hoehn & Yahr (H&Y) scale.

La Clinica terapeutica·2022

Instrumental Timed Up and Go test discloses abnormalities in patients with Cervical Dystonia.

Clinical biomechanics (Bristol, Avon)·2021

"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?"

Clinical neurology and neurosurgery·2019

Corticobasal syndrome: neuroimaging and neurophysiological advances.

European journal of neurology·2019

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters KCa2.2 vs. KCa3.1 Ligand Selectivity.

Archiv der Pharmazie·2026

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Science translational medicine·2026

Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.

Diabetes, obesity & metabolism·2026

Ameliorative Effects of Spirulina platensis Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.

Foods (Basel, Switzerland)·2026

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

JAMA network open·2026

相关实验视频

莱沃多巴度的波动和帕金森病.

相关概念视频

HD-MUNet: integrating artificial intelligence and high-density electromyography for motor unit number estimation.

Validity and reliability of the Italian version of the short Parkinson's evaluation scale (SPES/SCOPA).

Correlation between Quality of Life and severity of Parkinson's Disease by assessing an optimal cut-off point on the Parkinson's Disease questionnaire (PDQ-39) as related to the Hoehn & Yahr (H&Y) scale.

Instrumental Timed Up and Go test discloses abnormalities in patients with Cervical Dystonia.

"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?"

Corticobasal syndrome: neuroimaging and neurophysiological advances.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters K<sub>Ca</sub>2.2 vs. K<sub>Ca</sub>3.1 Ligand Selectivity.

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.

Ameliorative Effects of <i>Spirulina platensis</i> Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

相关实验视频

莱沃多巴度的波动和帕金森病.

相关概念视频

相关文章